|
Volumn 299, Issue 1, 2001, Pages 31-38
|
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
ALLOMETRY;
ANIMAL EXPERIMENT;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CHIMPANZEE;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DRUG POTENCY;
FEMALE;
GLOMERULUS FILTRATION RATE;
HALF LIFE TIME;
HUMAN;
HUMAN CELL;
MALE;
MOUSE;
MULTIGENE FAMILY;
NONHUMAN;
PREDICTION;
PRIMATE;
PRIORITY JOURNAL;
RAT;
TUMOR GROWTH;
ALGORITHMS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
COLORECTAL NEOPLASMS;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
MACACA FASCICULARIS;
MALE;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
PAN TROGLODYTES;
RATS;
RATS, SPRAGUE-DAWLEY;
SPECIES SPECIFICITY;
TNF-RELATED APOPTOSIS-INDUCING LIGAND;
TRANSPLANTATION, HETEROLOGOUS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0034812659
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (397)
|
References (22)
|